Orexigen Therapeutics, Inc. - 2012 Press Releases
Tom is interested in this field of Research...
Market Currents - Real-time stock market news updates - Seeking Alpha
2:30 PM Orexigen (OREX +17%) is another benificiary of Arena's (ARNA) good fortune today. Contrave is an investigational medication OREX has been working on that also focuses on the treatment of obesity, however it's still in the developmental stages. [Healthcare, On the Move] Comment!

See also...
View Later

Powered by        for:  Tom